Lipoprotein pattern and plasma lipoprotein lipase activities in patients with primary biliary cirrhosis: Relationship with increase of HDL2 fraction in Lp-X-positive and Lp-X-Negative subjects
The DOI matches its Crossref record, with a small difference in title or year; 46 of the 46 references it cites were found in a registry or an index.
Abstract
Plasma lipids, apoprotein A-I and B in serum and in lipoprotein fractions (VLDL + LDL, HDL2, and HDL3) obtained by preparative ultracentrifugation, as well as postheparin lipoprotein lipase activity (H-TGL and LPL) were evaluated in 17 subjects with primary biliary cirrhosis (stage II and III) subdivided into two groups according to the presence or absence of lipoprotein X (Lp-X). A reduction in total lipoprotein lipase activity was observed in both patient groups, compared to controls (P less than 0.01); the hepatic lipoprotein lipase was significantly reduced (P less than 0.01) only in the Lp-X-positive group. The lipid (477.8 +/- 154.3 vs 239.6 +/- 51.1; P less than 0.01) and protein (147.4 +/- 37.1 vs 83.3 +/- 19.7; P less than 0.01) masses in the VLDL + LDL fraction of the Lp-X-positive group were increased compared to controls. In the same group, the HDL2 fraction also showed an increase in lipid (186.6 +/- 80.0 vs 77.9 +/- 21.6; P less than 0.01) and protein (133.9 +/- 60.0 vs 67.9 +/- 16.5; P less than 0.01) masses; in addition, the HDL2 percent lipid composition was different in the two patient groups, showing a decrease in esterified cholesterol (20.4 +/- 3.6 vs 25.7 +/- 2.2; P less than 0.01) and an increase in phospholipids (59.2 +/- 2.9 vs 54.8 +/- 2.6; p less than 0.01) in the Lp-X-positive group.(ABSTRACT TRUNCATED AT 250 WORDS)
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Alendronate is a more effective treatment than etidronate, (255)”
From Primary Biliary Cholangitis: 2018 Practice Guidance from the American Association for the Study of Liver Diseases (2019) · cites this paper as [255]
In the citing paper
“but there are no studies to confirm the longterm efficacy of any treatment.”
From Primary Biliary Cholangitis: 2018 Practice Guidance from the American Association for the Study of Liver Diseases (2019) · cites this paper as [255]
Citations
Cites
PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENT
Lowry, O., Rosebrough, N., Farr, A. L., & Randall, R. (1951) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)52451-6 · Cited by 317,331
(1975) · Journal of AOAC INTERNATIONAL · doi:10.1093/jaoac/58.5.1085 · Cited by 19,795
Immunochemical quantitation of antigens by single radial immunodiffusion
Mancini, G., Carbonara, A. O., & Heremans, J. F. (1965) · Immunochemistry · doi:10.1016/0019-2791(65)90004-2 · Cited by 9,139
Enzymatic Determination of Total Serum Cholesterol
Allain, C. C., Poon, L. S., Chan, C. S. G., Richmond, W., & Fu, P. C. (1974) · Clinical Chemistry · doi:10.1093/clinchem/20.4.470 · Cited by 9,125
Rapid method for the isolation of lipoproteins from human serum by precipitation with polyanions
BURSTEIN, M., SCHOLNICK, H. R., & MORFIN, R. (1970) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)42943-8 · Cited by 2,491
Iversen, G. R. (2011) · International Encyclopedia of Statistical Science · doi:10.1007/978-3-642-04898-2_117 · Cited by 1,517
Microdetermination of plasma phospholipids by trichloroacetic acid precipitation.
Zilversmit, D. B., & Davis, A. K. (1950) · PubMed · Cited by 873
Gidez, L. I., Miller, G. J., Burstein, M., Slagle, S., & Eder, H. A. (1982) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)38059-7 · Cited by 757
Symposium: Advances in Liver Pathology [Abridged]: Primary Biliary Cirrhosis
Scheuer, P. J. (1967) · Proceedings of the Royal Society of Medicine · doi:10.1177/003591576706001205 · Cited by 557
Celaya, F. B. (1989) · Anales de Medicina Interna · Cited by 508
Cited by
(2011) · Encyclopedia of Cancer · doi:10.1007/978-3-642-16483-5_4730 · Cited by 1,240
Lindor, K. D., Gershwin, E. M., Poupon, R., Kaplan, M., Bergasa, N. V., & Heathcote, J. E. (2009) · Hepatology · doi:10.1002/hep.22906 · Cited by 1,099
Lindor, K. D., Bowlus, C. L., Boyer, J., Levy, C., & Mayo, M. (2019) · Hepatology · doi:10.1002/hep.30145 · Cited by 913
Primary biliary cirrhosis, hyperlipidemia, and atherosclerotic risk: A systematic review
Sorokin, A., Brown, J. L., & Thompson, P. D. (2007) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2006.11.036 · Cited by 167
5 Dyslipoproteinaemia of liver disease
Miller, J. P. (1990) · Baillière s Clinical Endocrinology and Metabolism · doi:10.1016/s0950-351x(05)80080-1 · Cited by 96
Cholesterol-lowering effect of ursodeoxycholic acid in patients with primary biliary cirrhosis
Poupon, R. E., Ouguerram, K., Chrétien, Y., Verneau, C., Eschwège, É., Magot, T., & Poupon, R. Y. (1993) · Hepatology · doi:10.1002/hep.1840170408 · Cited by 80
Lipoprotein–X in Patients With Cirrhosis: Its Relationship to Cholestasis and Hypercholesterolemia
Sörös, P., Böttcher, J., Maschek, H., Selberg, O., & Müller, M. J. (1998) · Hepatology · doi:10.1002/hep.510280506 · Cited by 48
Hiraoka, H., Yamashita, S., Matsuzawa, Y., Kubo, M., Nozaki, S., Sakai, N., Hirano, K., Kawata, S., & Tarui, S. (1993) · Hepatology · doi:10.1002/hep.1840180117 · Cited by 44
The liver steatosis severity and lipid characteristics in primary biliary cholangitis
Zhang, Y., Hu, X., Chang, J. K., Chen, J., Han, X., Zhang, T., Shen, J., Shang, N., Han, J., Wang, H., et al. (2021) · BMC Gastroenterology · doi:10.1186/s12876-021-01974-4 · Cited by 43
Iglesias, A., Arranz, M., Alvarez, J. J., Perales, J. C., Villar, J., Herrera, E., & Lasunción, M. A. (1996) · Clinica Chimica Acta · doi:10.1016/0009-8981(95)06251-3 · Cited by 36
Gottrand, F., Barthelemy-Clavey, V., Fruchart, J., & Farriaux, J. P. (1995) · Atherosclerosis · doi:10.1016/0021-9150(94)05521-j · Cited by 28
Pseudohyponatraemia in a patient with obstructive jaundice
le Riche, M., Burgess, L. J., & Marais, A. (2005) · Clinica Chimica Acta · doi:10.1016/j.cca.2005.10.004 · Cited by 21
Recent Insights into the Relationship between Inflammatory Liver Diseases and Atherosclerosis
Pürnak, T., Efe, C., Beyazıt, Y., Özaslan, E., Astan, R., Milanlıoğlu, A., Özbalkan, Z., & Rizzo, M. (2011) · Journal of Investigative Medicine · doi:10.2310/jim.0b013e318217f3a0 · Cited by 16
Lazaridis, K. N., & Lindor, K. D. (1999) · Current Treatment Options in Gastroenterology · doi:10.1007/s11938-999-0051-0 · Cited by 12
Bergasa, N. V. (2021) · Springer eBooks · doi:10.1007/978-1-4471-4715-2_3 · Cited by 5
le Riche, M. (2007) · SUNScholar (Stellenbosch University) · Cited by 1
Zhang, Y., Hu, X., Chang, J., Chen, J., Han, X., Zhang, T., Shen, J., Shang, N., Han, J., Wang, H., et al. (2021) · Figshare · doi:10.6084/m9.figshare.16862872
Pseudohyponatremia in a neuroblastoma patient with obstructive jaundice and review of literature
Bassi, M., Manzitti, C., Montalto, S., Giglio, S., Conte, M., Facco, F., & Amoroso, L. (2021) · Clinical Case Reports and Reviews · doi:10.15761/ccrr.1000504
Metadata
- Authors
- Baldo-Enzi, G., Baiocchi, M. R., Grotto, M., Floreani, A. R., Zagolin, M., Chiaramonte, M., Cera, F., & Fellin, R.
- Affiliations
- University of Padua (IT)
- ORCID
- Fellin, Renato
- Venue
- Digestive Diseases and Sciences
- Published
- 1988-10
- Volume
- 33
- Issue
- 10
- Pages
- 1201-1207
- ISSN
- 0163-2116 (ISSN-L)
- 1573-2568
- OpenAlex
- W2076922956
- Cited by
- 18
- References
- 46
- Citations by year
- 2021: 4 · 2018: 1
- FWCI
- 0.36
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Digestive Diseases and Sciences (publishedVersion)
- PubMed (publishedVersion)
- Padua Research Archive (University of Padova) (submittedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
- Health Sciences › Medicine › Hepatology › Liver Diseases and Immunity
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
- Keywords
- primary biliary cirrhosis, lipoprotein X, lipoprotein lipase, hepatic lipase, apolipoprotein A-I, apolipoprotein B, HDL2, HDL3, VLDL, low-density lipoprotein, plasma lipids, lipoprotein composition, esterified cholesterol, phospholipids
- MeSH terms
- Apolipoproteins B, Cholesterol Esters, Female, Humans, Lipoprotein Lipase, Lipoprotein-X, Lipoproteins, Lipoproteins, HDL, Lipoproteins, LDL, Lipoproteins, VLDL, Liver Cirrhosis, Biliary, Male, Middle Aged, Phospholipids, Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.